Editorial: Intestinal Dysbiosis in Inflammatory Diseases
- PMID: 34394133
- PMCID: PMC8362080
- DOI: 10.3389/fimmu.2021.727485
Editorial: Intestinal Dysbiosis in Inflammatory Diseases
Keywords: dysbiosis; gut microbiota; gut permeability; inflammatory diseases; microbiota modulators.
Conflict of interest statement
AF holds stocks in Alba Therapeutics and receives financial support from Takeda Pharmaceuticals. VT has received financial support from Elysium Health and Evelo Biosciences. The remaining authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Comment on
- Editorial on Research TopicIntestinal Dysbiosis in Inflammatory Diseases
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources